Literature DB >> 6274199

Neutrophil-degranulating action of 5,12-dihydroxy-6,8,10,14-eicosatetraenoic acid and 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine. Comparison with other degranulating agents.

J T O'Flaherty, R L Wykle, C J Lees, T Shewmake, C E McCall, M J Thomas.   

Abstract

5,12-Dihydroxy-6,8,10,14-eicosatetraenoic acid was prepared from rabbit neutrophils challenged with ionophore A23187 plus arachidonic acid. It was purified by reverse-phase high-performance liquid chromatography with the use of a two-step procedure that effectively resolved the lipid from closely eluting contaminants. The phospholipid 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine was prepared from beef heart plasmalogen. Confirming earlier reports, both lipids stimulated human polymorphonuclear neutrophils to release granule-bound enzymes. Their respective degranulating actions took less than 5 minutes to become maximal, were dependent upon the presence of cytochalasin B, and required intact pathways of arachidonic acid metabolism, as judged by the inhibitory actions of arachidonate antimetabolites. Neither lipid required more than trace concentrations of extracellular calcium to effect optimal amounts of enzyme release. In one or more of these regards the two lipids differed strikingly from other neutrophil-degranulating agents such as A23187, N-formyl-methionyl-leucyl-phenylalanine, and phorbol myristate acetate. The mechanism of action of the two lipid stimuli, therefore, appear to differ somewhat from the mechanisms of the other three stimuli.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6274199      PMCID: PMC1903896     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  20 in total

1.  The effects of extracellular K+, Na+ and Ca++ on lysosomal enzyme secretion from polymorphonuclear leukocytes.

Authors:  H J Showell; P H Naccache; R I Sha'afi; E L Becker
Journal:  J Immunol       Date:  1977-09       Impact factor: 5.422

2.  Calcium-induced lysozyme secretion from human polymorphonuclear leukocytes.

Authors:  I M Goldstein; J K Horn; H B Kaplan; G Weissmann
Journal:  Biochem Biophys Res Commun       Date:  1974-09-23       Impact factor: 3.575

3.  Secretagogues for lysosomal enzyme release as stimulants of arachidonyl phosphatidylinositol turnover in rabbit neutrophils.

Authors:  R P Rubin; L E Sink; M P Schrey; A R Day; C S Liao; R J Freer
Journal:  Biochem Biophys Res Commun       Date:  1979-10-29       Impact factor: 3.575

4.  Arachidonate metabolite(s) increase the permeability of the plasma membrane of the neutrophils to calcium.

Authors:  M Volpi; P H Naccache; R I Sha'afi
Journal:  Biochem Biophys Res Commun       Date:  1980-02-27       Impact factor: 3.575

5.  Arachidonic acid metabolism in polymorphonuclear leukocytes: effects of ionophore A23187.

Authors:  P Borgeat; B Samuelsson
Journal:  Proc Natl Acad Sci U S A       Date:  1979-05       Impact factor: 11.205

6.  The sequential release of granule constitutents from human neutrophils.

Authors:  B J Bentwood; P M Henson
Journal:  J Immunol       Date:  1980-02       Impact factor: 5.422

7.  Effect of various lipoxygenase metabolites of arachidonic acid on degranulation of polymorphonuclear leukocytes.

Authors:  G M Bokoch; P W Reed
Journal:  J Biol Chem       Date:  1981-06-10       Impact factor: 5.157

8.  A possible role of arachidonic acid in human neutrophil aggregation and degranulation.

Authors:  J T O'Flaherty; H J Showell; P A Ward; E L Becker
Journal:  Am J Pathol       Date:  1979-09       Impact factor: 4.307

9.  Cytochalasin B-dependent release of azurophil granule enzymes from human polymorphonuclear leukocytes.

Authors:  E C Yurewicz; M Zimmerman
Journal:  Inflammation       Date:  1977-12       Impact factor: 4.092

10.  Changes in ionic movements across rabbit polymorphonuclear leukocyte membranes during lysosomal enzyme release. Possible ionic basis for lysosomal enzyme release.

Authors:  P H Naccache; H J Showell; E L Becker; R I Sha'afi
Journal:  J Cell Biol       Date:  1977-12       Impact factor: 10.539

View more
  14 in total

1.  Leukotriene b4 and its metabolites prime the neutrophil oxidase and induce proinflammatory activation of human pulmonary microvascular endothelial cells.

Authors:  John C Eun; Ernest E Moore; Anirban Banerjee; Marguerite R Kelher; Samina Y Khan; David J Elzi; Nathan J D McLaughlin; Christopher C Silliman
Journal:  Shock       Date:  2011-03       Impact factor: 3.454

2.  Biological response of guinea pig peritoneal macrophages to platelet-activating factor.

Authors:  H Hayashi; I Kudo; S Nojima; K Inoue
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

3.  Inhibition of leukotriene formation and IL-8 release by the paf-receptor antagonist SM-12502.

Authors:  R A Hilger; M Köller; W König
Journal:  Inflammation       Date:  1996-02       Impact factor: 4.092

Review 4.  Biology and biochemistry of platelet-activating factor.

Authors:  J T O'Flaherty; R L Wykle
Journal:  Clin Rev Allergy       Date:  1983-09

5.  Pulmonary injury induced by phorbol myristate acetate following intravenous administration in rabbits. Acute respiratory distress followed by pulmonary interstitial pneumonitis and pulmonary fibrosis.

Authors:  C E McCall; R G Taylor; S L Cousart; R D Woodruff; J C Lewis; J T O'Flaherty
Journal:  Am J Pathol       Date:  1983-05       Impact factor: 4.307

6.  Activation of human neutrophil LFA-1 (CD11a) by leukotriene B4.

Authors:  R S Shames; E J Goetzl
Journal:  Inflammation       Date:  1993-06       Impact factor: 4.092

7.  Human T-lymphocyte subset specificity of the regulatory effects of leukotriene B4.

Authors:  D G Payan; A Missirian-Bastian; E J Goetzl
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

8.  The in vivo effect of leukotriene B4 on polymorphonuclear leukocytes and the microcirculation. Comparison with activated complement (C5a des Arg) and enhancement by prostaglandin E2.

Authors:  H Z Movat; C Rettl; C E Burrowes; M G Johnston
Journal:  Am J Pathol       Date:  1984-05       Impact factor: 4.307

9.  Enhancement of human polymorphonuclear leukocyte adherence by the phospholipid mediator 1-O-hexadecyl-2-acetyl-sn-glycero-3-phosphorylcholine (AGEPC).

Authors:  F H Valone; E J Goetzl
Journal:  Am J Pathol       Date:  1983-10       Impact factor: 4.307

10.  Enhancement of human neutrophil adherence by synthetic leukotriene constituents of the slow-reacting substance of anaphylaxis.

Authors:  E J Goetzl; L L Brindley; D W Goldman
Journal:  Immunology       Date:  1983-09       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.